142 related articles for article (PubMed ID: 37035453)
1. Hepatocellular carcinoma in Pacific Islanders: comparison of Pacific Island-born
Yee SK; Hernandez BY; Kwee S; Wong LL
Hepatoma Res; 2023; 9():. PubMed ID: 37035453
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular cancer: risk factors and survival in Pacific Islanders compared to Caucasians in Hawaii.
Ochner M; Wong LL; Wimmer-Kunitomo K
Ethn Dis; 2010; 20(2):169-73. PubMed ID: 20503898
[TBL] [Abstract][Full Text] [Related]
3. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in Micronesians, a growing Pacific Islander population in the U.S.
Wu EM; Hernandez BY; Wong LL
Open J Gastroenterol; 2018; 8(6):. PubMed ID: 30079276
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
6. Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer.
Wong LL; Hernandez B; Kwee S; Albright CL; Okimoto G; Tsai N
Am J Surg; 2012 Jun; 203(6):726-32. PubMed ID: 22227170
[TBL] [Abstract][Full Text] [Related]
7. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Ethnic Subgroups on Tumor Stage at Diagnosis, Treatment Received, and Long-Term Survival Among Asian Adults With Hepatocellular Carcinoma.
Yu JR; Wang J; Bhuket T; Liu B; Wong RJ
J Clin Exp Hepatol; 2019; 9(2):182-190. PubMed ID: 31024200
[TBL] [Abstract][Full Text] [Related]
9. Increased morbidity and mortality of hepatocellular carcinoma patients in lower cost of living areas.
Sempokuya T; Patel KP; Azawi M; Ma J; Wong LL
World J Clin Cases; 2021 Aug; 9(23):6734-6746. PubMed ID: 34447820
[TBL] [Abstract][Full Text] [Related]
10. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B surface antigen in US-born and foreign-born Asian/Pacific Islander college students.
Quang YN; Vu J; Yuk J; Li CS; Chen M; Bowlus CL
J Am Coll Health; 2010; 59(1):37-41. PubMed ID: 20670927
[TBL] [Abstract][Full Text] [Related]
12. Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease.
Tan YW; Wang JM; Zhou XB
World J Hepatol; 2023 Feb; 15(2):237-254. PubMed ID: 36926239
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma.
Sempokuya T; Wien EA; Pattison RJ; Ma J; Wong LL
World J Hepatol; 2020 Nov; 12(11):1020-1030. PubMed ID: 33312426
[TBL] [Abstract][Full Text] [Related]
14. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma.
Mohsen W; Rodov M; Prakoso E; Charlton B; Bowen DG; Koorey DJ; Shackel NA; McCaughan GW; Strasser SI
World J Gastroenterol; 2017 Apr; 23(15):2763-2770. PubMed ID: 28487614
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
16. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
17. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
Hassan I; Gane E
Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
[TBL] [Abstract][Full Text] [Related]
18. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Phan J; Ng V; Sheinbaum A; French S; Choi G; El Kabany M; Durazo F; Saab S; Tong M; Busuttil R; Han SH
J Clin Gastroenterol; 2019 Apr; 53(4):309-313. PubMed ID: 29912756
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
Liew ZH; Goh GB; Hao Y; Chang PE; Tan CK
Dig Dis Sci; 2019 Feb; 64(2):585-590. PubMed ID: 30327962
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
